Navigation Links
Damian Dell'Anno Joins Formation Capital as Chief Operating Officer
Date:4/22/2008

ALPHARETTA, Ga., April 22 /PRNewswire/ -- Formation Capital, LLC is pleased to announce that Damian N. Dell'Anno, former CEO of Harborside Healthcare, has joined the company as Senior Executive Vice President and Chief Operating Officer. In this role, he will be leading the day-to-day operations and direction of the organization. He brings with him 26+ years expertise in leading change, building shareholder value, and managing Board and investor expectations. He has a demonstrated track record of developing new businesses, driving mergers and acquisitions, and raising capital through leading and developing high-quality, rapid-growth teams and organizations.

"Damian brings a wealth of operating experience and organizational skills that are extremely complementary to Formation Capital's investment strategy," said Arnold Whitman, CEO. "We are very excited about the addition of Damian. He is one of the most respected professionals in the long-term care industry."

Prior to joining Formation Capital he was co-founder of Next Step Healthcare in April 2007. Previously he was with Harborside Healthcare for 17 years where he served as Chief Operating Officer since 1994, President since 2001, and Chief Executive Officer and Chairman since 2005. He served as head of Harborside's specialty services group and was instrumental in the initial development of Theracor, Harborside's rehabilitation therapy company.

Prior to joining Harborside, Mr. Dell'Anno served as Director of Budget, Reimbursement, and Cash Management for the Mediplex Group, Inc. In addition, he has held several other positions in the senior housing and healthcares services sector. Mr. Dell'Anno is a past member of the Alliance for Quality Nursing Home Care, and the Massachusetts and Ohio Nursing Home Associations.

Mr. Dell'Anno is presently a member of the Board of Directors of the Connecticut Association for Healthcare Facilities and serves as Chairman of the Board of Directors,
'/>"/>

SOURCE Formation Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... between Hewlett Packard and the government in Nor...r prescriptions towards the implementation// of an...lth Social Services and Public Safety has announce...ern Ireland will be equipped with an electronic sy...
...ll have a new medical college from the next academ...ednesday that the proposed medical college will be...n addition to the new campus of the Rajiv Gandhi U... said, "The revenue department will identify alter...
...has revealed that those who drink coffee very rare...heavy drinkers.// According to a study in the Sep...ple could get a heart attack within one hour of ha...k of almost 60% amongst moderate coffee drinkers, ...
..."Pascal" Norris, who died in July, is thought to b...an two decades in Scotland. NHS Borders revealed t...ied on 8 July in Edinburgh Royal Infirmary and lat...died of anthrax. Health Protection Scotland said ...
Other Medicine News:
(Date:7/23/2008)... Protein Therapeutics that Modulate Alte...Mass., July 23 /- Taligen Therapeutic...e growth plan with the,appointment of Abbie Celnik...blishment of its headquarters in Cambridge, Mass. ...ounder of the company who remains president., Und...
(Date:7/22/2008)...ent Initiative bring MJFF,s,current active industr...2009, NEW YORK, July 22 /PRNewswire-USNewswire/ -...sformative treatments and a cure for Parkinson,s,d...n,s Research has awarded,$2.7 million in total fun...re granted under MJFF,s Therapeutics Development I...
(Date:7/22/2008)...a(R) Resulted in Significant, Reductions in A1C in...ithm Used, BRIDG... the "Adjust to,Target in Type 2 Diabetes: Compari... for Adjustment of Mealtime Insulin Glulisine" stu...ation,s (ADA) medical journal,Diabetes Care. This...
(Date:7/22/2008)...ersity Medical Center Based on Rosetta G...st Differentiates Squamous From Non-Squamous Non-S...us-Cell Carcinoma of the Lung With Sensitiv...is is the First CLIA Approved Test Which Leverages... Accurate Diagnosis of Lung Cancer, REHOVOT, Isra...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Hip replacement improves function saves money at any age 21969 1Hip replacement improves function saves money at any age 21969 2LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 1LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 2Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 1Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 2Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 1Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 2
... patients taking,once-daily Lialda remained relaps...May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term... (303),presented at the British Society of Gastroe...rch 2007 showed Shire plc,s,Lialda(mesalamine) is ...day, secondary endpoints of study 303 were present...
... Doses, According to,New Data Presented at Digesti...wswire/ -- UCB announced today that,new data prese...ated long-term response and remission in Crohn,s d...pegol), the only Fc-free,PEGylated, Fab, fragment ... long-term open label,continuation of the Phase II...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: